News

Nasdaq19d
Validea Detailed Fundamental Analysis - LLY - Nasdaq
Below is Validea's guru fundamental report for ELI LILLY AND CO (LLY). Of the 22 guru strategies we follow, LLY rates highest using our P/B Growth Investor model based on the published strategy of ...
Yahoo Finance27d
Eli Lilly (LLY)’s Target Price Slashed to $960 by TD Cowen, Reiterates Buy Rating - Yahoo Finance
On June 5, TD Cowen analysts trimmed the price target for Eli Lilly and Company (NYSE:LLY) from $1,050 to $960, while reiterating a Buy rating on the stock. This target price adjustment aligns ...
Benzinga.com28d
Mounjaro Maker Eli Lilly Taps Swedish Firm Camurus To Target Long-Acting Obesity Market In $870-Million Deal - Eli Lilly (NYSE:LLY) - Benzinga
Camurus licensed its FluidCrystal drug delivery tech to Eli Lilly for global development of long-acting incretin therapies targeting metabolic diseases.